globenewswire

VECT-HORUS appoints Dr Jamal Temsamani as Director of Drug Development & Corporate

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 30 October 2014 06:16

MARSEILLE, France, Oct. 30, 2014 (GLOBE NEWSWIRE)

Read more...
 

KLAS Ranks Premier, Inc.'s ACO Advisory Services #1

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 30 October 2014 05:01

CHARLOTTE, N.C., Oct. 30, 2014 (GLOBE NEWSWIRE)

Read more...
 

Merit Medical and Bard Access Systems, Inc. Settle Dispute

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 30 October 2014 03:30

SOUTH JORDAN, Utah, Oct. 30, 2014 (GLOBE NEWSWIRE)

Read more...
 

Ultragenyx Granted EU Orphan Drug Designation for KRN23 for the Treatment of X-Linked Hypophosphatemia

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 30 October 2014 03:00

Novato, CA, Oct. 30, 2014 (GLOBE NEWSWIRE)

Read more...
 

Avalanche Biotechnologies to Participate in Nomura's Biotechnology Conference

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 30 October 2014 03:00

MENLO PARK, Calif., Oct. 30, 2014 (GLOBE NEWSWIRE)

Read more...
 

AXIM Biotechnologies Delivers Net Negative Carbon Footprint With All-Natural Industrial Hemp

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 30 October 2014 03:00

NEW YORK, Oct. 30, 2014 (GLOBE NEWSWIRE)

Read more...
 

Chembio's DPP(R) HIV 1/2 Assay Receives CLIA Waiver From FDA

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 30 October 2014 02:50

MEDFORD, N.Y., Oct. 30, 2014 (GLOBE NEWSWIRE)

Read more...
 

Enzymotec to Report Third Quarter Fiscal Year 2014 Financial Results

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 30 October 2014 02:30

MIGDAL HA'EMEQ, Israel, Oct. 30, 2014 (GLOBE NEWSWIRE)

Read more...
 

Cancer Genetics, Inc. to Report Third Quarter 2014 Financial Results on Monday, November 10

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 30 October 2014 02:30

RUTHERFORD, N.J., Oct. 30, 2014 (GLOBE NEWSWIRE)

Read more...
 

Novavax to Host Conference Call to Discuss Third Quarter 2014 Financial Results on November 5, 2014

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 30 October 2014 02:30

GAITHERSBURG, Md., Oct. 30, 2014 (GLOBE NEWSWIRE)

Read more...
 

Versartis Schedules Conference Call to Discuss Plans for Phase 3 Trial for VRS-317 in Pediatric Growth Hormone Deficiency Patients

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 30 October 2014 02:30

MENLO PARK, Calif., Oct. 30, 2014 (GLOBE NEWSWIRE)

Read more...
 

Hemispherx Biopharma Reports New Evidence -- Based Potential of Ampligen(R) Against Ebola Virus Disease (EVD)

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 30 October 2014 02:30

PHILADELPHIA, Oct. 30, 2014 (GLOBE NEWSWIRE)

Read more...
 

OncoMed to Present Clinical and Preclinical Data at the 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics Meeting

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 30 October 2014 02:30

REDWOOD CITY, Calif., Oct. 30, 2014 (GLOBE NEWSWIRE)

Read more...
 

Oculus Innovative Sciences Receives European CE Mark for New Microcyn(R)-Based Atopic Dermatitis Hydrogel

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 30 October 2014 02:12

• New Pediacyn™ Hydrogel to be Introduced at Medica Education Conference on November 12-15 in Dusseldorf, Germany

ROERMOND, Netherlands and PETALUMA, Calif., Oct. 30, 2014 (GLOBE NEWSWIRE)

Read more...
 

Relypsa to Present at Nomura Biotechnology Conference

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 30 October 2014 02:00

REDWOOD CITY, Calif., Oct. 30, 2014 (GLOBE NEWSWIRE)

Read more...
 
<< Start < Prev 1 3 4 5 6 7 8 9 10 > End >>

Page 1 of 448